IBDEI34V ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50042,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50042,1,3,0)
;;=3^Atopic Dermatitis NEC
;;^UTILITY(U,$J,358.3,50042,1,4,0)
;;=4^L20.89
;;^UTILITY(U,$J,358.3,50042,2)
;;=^5009112
;;^UTILITY(U,$J,358.3,50043,0)
;;=L20.9^^193^2487^87
;;^UTILITY(U,$J,358.3,50043,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50043,1,3,0)
;;=3^Atopic Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,50043,1,4,0)
;;=4^L20.9
;;^UTILITY(U,$J,358.3,50043,2)
;;=^5009113
;;^UTILITY(U,$J,358.3,50044,0)
;;=L21.8^^193^2487^302
;;^UTILITY(U,$J,358.3,50044,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50044,1,3,0)
;;=3^Seborrheic Dermatitis NEC
;;^UTILITY(U,$J,358.3,50044,1,4,0)
;;=4^L21.8
;;^UTILITY(U,$J,358.3,50044,2)
;;=^303310
;;^UTILITY(U,$J,358.3,50045,0)
;;=L21.9^^193^2487^303
;;^UTILITY(U,$J,358.3,50045,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50045,1,3,0)
;;=3^Seborrheic Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,50045,1,4,0)
;;=4^L21.9
;;^UTILITY(U,$J,358.3,50045,2)
;;=^188703
;;^UTILITY(U,$J,358.3,50046,0)
;;=L23.7^^193^2487^31
;;^UTILITY(U,$J,358.3,50046,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50046,1,3,0)
;;=3^Allergic Contact Dermatitis d/t Plants
;;^UTILITY(U,$J,358.3,50046,1,4,0)
;;=4^L23.7
;;^UTILITY(U,$J,358.3,50046,2)
;;=^5009122
;;^UTILITY(U,$J,358.3,50047,0)
;;=L23.9^^193^2487^32
;;^UTILITY(U,$J,358.3,50047,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50047,1,3,0)
;;=3^Allergic Contact Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,50047,1,4,0)
;;=4^L23.9
;;^UTILITY(U,$J,358.3,50047,2)
;;=^5009125
;;^UTILITY(U,$J,358.3,50048,0)
;;=L24.9^^193^2487^166
;;^UTILITY(U,$J,358.3,50048,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50048,1,3,0)
;;=3^Irritant Contact Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,50048,1,4,0)
;;=4^L24.9
;;^UTILITY(U,$J,358.3,50048,2)
;;=^5009136
;;^UTILITY(U,$J,358.3,50049,0)
;;=L25.9^^193^2487^117
;;^UTILITY(U,$J,358.3,50049,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50049,1,3,0)
;;=3^Contact Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,50049,1,4,0)
;;=4^L25.9
;;^UTILITY(U,$J,358.3,50049,2)
;;=^5133647
;;^UTILITY(U,$J,358.3,50050,0)
;;=L26.^^193^2487^151
;;^UTILITY(U,$J,358.3,50050,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50050,1,3,0)
;;=3^Exfoliative Dermatitis
;;^UTILITY(U,$J,358.3,50050,1,4,0)
;;=4^L26.
;;^UTILITY(U,$J,358.3,50050,2)
;;=^263886
;;^UTILITY(U,$J,358.3,50051,0)
;;=L27.0^^193^2487^305
;;^UTILITY(U,$J,358.3,50051,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50051,1,3,0)
;;=3^Skin Eruption d/t Drugs/Meds,Generalized
;;^UTILITY(U,$J,358.3,50051,1,4,0)
;;=4^L27.0
;;^UTILITY(U,$J,358.3,50051,2)
;;=^5009144
;;^UTILITY(U,$J,358.3,50052,0)
;;=L27.1^^193^2487^306
;;^UTILITY(U,$J,358.3,50052,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50052,1,3,0)
;;=3^Skin Eruption d/t Drugs/Meds,Localized
;;^UTILITY(U,$J,358.3,50052,1,4,0)
;;=4^L27.1
;;^UTILITY(U,$J,358.3,50052,2)
;;=^5009145
;;^UTILITY(U,$J,358.3,50053,0)
;;=L29.0^^193^2487^290
;;^UTILITY(U,$J,358.3,50053,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50053,1,3,0)
;;=3^Pruritus Ani
;;^UTILITY(U,$J,358.3,50053,1,4,0)
;;=4^L29.0
;;^UTILITY(U,$J,358.3,50053,2)
;;=^100061
;;^UTILITY(U,$J,358.3,50054,0)
;;=L29.9^^193^2487^291
;;^UTILITY(U,$J,358.3,50054,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50054,1,3,0)
;;=3^Pruritus,Unspec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34V 3751 printed Apr 09, 2024@21:13:42 Page 2
IBDEI34V ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50042,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,50042,1,3,0)
+4 ;;=3^Atopic Dermatitis NEC
+5 ;;^UTILITY(U,$J,358.3,50042,1,4,0)
+6 ;;=4^L20.89
+7 ;;^UTILITY(U,$J,358.3,50042,2)
+8 ;;=^5009112
+9 ;;^UTILITY(U,$J,358.3,50043,0)
+10 ;;=L20.9^^193^2487^87
+11 ;;^UTILITY(U,$J,358.3,50043,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,50043,1,3,0)
+14 ;;=3^Atopic Dermatitis,Unspec
+15 ;;^UTILITY(U,$J,358.3,50043,1,4,0)
+16 ;;=4^L20.9
+17 ;;^UTILITY(U,$J,358.3,50043,2)
+18 ;;=^5009113
+19 ;;^UTILITY(U,$J,358.3,50044,0)
+20 ;;=L21.8^^193^2487^302
+21 ;;^UTILITY(U,$J,358.3,50044,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,50044,1,3,0)
+24 ;;=3^Seborrheic Dermatitis NEC
+25 ;;^UTILITY(U,$J,358.3,50044,1,4,0)
+26 ;;=4^L21.8
+27 ;;^UTILITY(U,$J,358.3,50044,2)
+28 ;;=^303310
+29 ;;^UTILITY(U,$J,358.3,50045,0)
+30 ;;=L21.9^^193^2487^303
+31 ;;^UTILITY(U,$J,358.3,50045,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,50045,1,3,0)
+34 ;;=3^Seborrheic Dermatitis,Unspec
+35 ;;^UTILITY(U,$J,358.3,50045,1,4,0)
+36 ;;=4^L21.9
+37 ;;^UTILITY(U,$J,358.3,50045,2)
+38 ;;=^188703
+39 ;;^UTILITY(U,$J,358.3,50046,0)
+40 ;;=L23.7^^193^2487^31
+41 ;;^UTILITY(U,$J,358.3,50046,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,50046,1,3,0)
+44 ;;=3^Allergic Contact Dermatitis d/t Plants
+45 ;;^UTILITY(U,$J,358.3,50046,1,4,0)
+46 ;;=4^L23.7
+47 ;;^UTILITY(U,$J,358.3,50046,2)
+48 ;;=^5009122
+49 ;;^UTILITY(U,$J,358.3,50047,0)
+50 ;;=L23.9^^193^2487^32
+51 ;;^UTILITY(U,$J,358.3,50047,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,50047,1,3,0)
+54 ;;=3^Allergic Contact Dermatitis,Unspec
+55 ;;^UTILITY(U,$J,358.3,50047,1,4,0)
+56 ;;=4^L23.9
+57 ;;^UTILITY(U,$J,358.3,50047,2)
+58 ;;=^5009125
+59 ;;^UTILITY(U,$J,358.3,50048,0)
+60 ;;=L24.9^^193^2487^166
+61 ;;^UTILITY(U,$J,358.3,50048,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,50048,1,3,0)
+64 ;;=3^Irritant Contact Dermatitis,Unspec
+65 ;;^UTILITY(U,$J,358.3,50048,1,4,0)
+66 ;;=4^L24.9
+67 ;;^UTILITY(U,$J,358.3,50048,2)
+68 ;;=^5009136
+69 ;;^UTILITY(U,$J,358.3,50049,0)
+70 ;;=L25.9^^193^2487^117
+71 ;;^UTILITY(U,$J,358.3,50049,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,50049,1,3,0)
+74 ;;=3^Contact Dermatitis,Unspec
+75 ;;^UTILITY(U,$J,358.3,50049,1,4,0)
+76 ;;=4^L25.9
+77 ;;^UTILITY(U,$J,358.3,50049,2)
+78 ;;=^5133647
+79 ;;^UTILITY(U,$J,358.3,50050,0)
+80 ;;=L26.^^193^2487^151
+81 ;;^UTILITY(U,$J,358.3,50050,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,50050,1,3,0)
+84 ;;=3^Exfoliative Dermatitis
+85 ;;^UTILITY(U,$J,358.3,50050,1,4,0)
+86 ;;=4^L26.
+87 ;;^UTILITY(U,$J,358.3,50050,2)
+88 ;;=^263886
+89 ;;^UTILITY(U,$J,358.3,50051,0)
+90 ;;=L27.0^^193^2487^305
+91 ;;^UTILITY(U,$J,358.3,50051,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,50051,1,3,0)
+94 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
+95 ;;^UTILITY(U,$J,358.3,50051,1,4,0)
+96 ;;=4^L27.0
+97 ;;^UTILITY(U,$J,358.3,50051,2)
+98 ;;=^5009144
+99 ;;^UTILITY(U,$J,358.3,50052,0)
+100 ;;=L27.1^^193^2487^306
+101 ;;^UTILITY(U,$J,358.3,50052,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,50052,1,3,0)
+104 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
+105 ;;^UTILITY(U,$J,358.3,50052,1,4,0)
+106 ;;=4^L27.1
+107 ;;^UTILITY(U,$J,358.3,50052,2)
+108 ;;=^5009145
+109 ;;^UTILITY(U,$J,358.3,50053,0)
+110 ;;=L29.0^^193^2487^290
+111 ;;^UTILITY(U,$J,358.3,50053,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,50053,1,3,0)
+114 ;;=3^Pruritus Ani
+115 ;;^UTILITY(U,$J,358.3,50053,1,4,0)
+116 ;;=4^L29.0
+117 ;;^UTILITY(U,$J,358.3,50053,2)
+118 ;;=^100061
+119 ;;^UTILITY(U,$J,358.3,50054,0)
+120 ;;=L29.9^^193^2487^291
+121 ;;^UTILITY(U,$J,358.3,50054,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,50054,1,3,0)
+124 ;;=3^Pruritus,Unspec
